Strides Pharma Science (STAR.NS) Stock Price

Strides Pharma Science Price

NSE·CLOSED
1,059.60INR-11.50 (-1.08 %)
Market closed

Over the last 20 years Strides Pharma Science grew revenue by 11.4% annually, reaching 45.65 B INR. Earnings per share have grown at 19.0% per year over the last 20 years. For Strides Pharma Science, the net margin of 78.7% is up versus 8.1% a few years ago. At today's price the dividend yield works out to roughly 0.38%. The payout ratio is around 1% of earnings. The dividend has grown at 5.0% per year over the past 20 years. The consensus 12-month price target for Strides Pharma Science is 1,252.56 INR, about 18.2% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 34% above its 52-week low.

Strides Pharma Science stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Strides Pharma Science over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Strides Pharma Science stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Strides Pharma Science's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Strides Pharma Science Stock Price History
DateStrides Pharma Science Price
7/15/20261,059.60 INR
7/14/20261,071.10 INR
7/13/20261,074.00 INR
7/10/20261,082.60 INR
7/9/20261,076.00 INR
7/8/20261,080.80 INR
7/7/20261,127.20 INR
7/3/20261,127.80 INR
7/2/20261,126.40 INR
7/1/20261,094.10 INR
6/30/20261,092.90 INR
6/29/20261,103.40 INR
6/25/20261,082.20 INR
6/24/20261,111.30 INR
6/23/20261,111.20 INR
6/22/20261,116.20 INR
6/19/20261,118.30 INR
6/18/20261,127.80 INR
6/17/20261,111.00 INR
6/16/20261,097.10 INR
6/15/20261,098.90 INR
6/12/2026992.50 INR
6/11/2026992.40 INR
6/10/2026975.10 INR
6/9/20261,017.00 INR
6/8/20261,005.70 INR
6/5/20261,021.90 INR
6/4/20261,027.20 INR
6/3/20261,081.20 INR
6/2/20261,075.00 INR
6/1/20261,118.10 INR
5/29/20261,152.70 INR
5/27/20261,163.50 INR
5/26/20261,199.80 INR
5/25/20261,178.00 INR
5/22/20261,158.90 INR
5/21/20261,131.80 INR
5/20/20261,171.80 INR
5/19/20261,153.60 INR
5/18/20261,151.40 INR
5/15/20261,153.70 INR
5/14/20261,155.40 INR
5/13/20261,146.40 INR
5/12/20261,151.80 INR
5/11/20261,156.20 INR
5/8/20261,156.90 INR
5/7/20261,146.80 INR
5/6/20261,098.00 INR
5/5/20261,052.10 INR
5/4/20261,031.50 INR
5/1/20261,036.80 INR
4/30/20261,036.80 INR
4/29/20261,053.45 INR
4/28/20261,051.95 INR
4/27/20261,098.55 INR
4/24/20261,066.25 INR
4/23/20261,069.00 INR
4/22/20261,002.05 INR
4/21/2026996.95 INR
4/20/2026996.50 INR
4/17/20261,000.25 INR
4/16/2026993.90 INR
4/15/20261,001.65 INR
4/13/20261,001.15 INR
4/10/20261,000.00 INR
4/9/2026996.25 INR
4/8/2026964.40 INR
4/7/2026994.10 INR
4/6/2026981.05 INR
4/2/2026971.15 INR
4/1/2026954.20 INR
3/30/2026929.55 INR
3/27/2026935.00 INR
3/25/2026925.40 INR
3/24/2026911.00 INR
3/23/2026899.00 INR
3/20/2026904.00 INR
3/19/2026897.60 INR
3/18/2026903.00 INR
3/17/2026875.00 INR
3/16/2026886.00 INR
3/13/2026912.20 INR
3/12/2026910.10 INR
3/11/2026887.00 INR
3/10/2026873.00 INR
3/9/2026869.10 INR
3/6/2026858.00 INR
3/5/2026848.00 INR
2/27/2026851.55 INR
2/26/2026860.00 INR
2/25/2026860.15 INR
2/23/2026870.60 INR
2/20/2026870.00 INR
2/19/2026875.00 INR
2/18/2026876.00 INR
2/17/2026871.00 INR
2/16/2026859.00 INR
2/13/2026859.60 INR
2/12/2026867.00 INR
2/11/2026876.00 INR
2/10/2026878.10 INR
2/9/2026882.65 INR
2/6/2026865.00 INR
2/5/2026861.80 INR
2/4/2026866.50 INR
2/3/2026875.50 INR
2/2/2026836.55 INR
1/30/2026876.10 INR
1/29/2026809.75 INR
1/28/2026795.00 INR
1/27/2026791.65 INR
1/23/2026800.25 INR
1/22/2026864.60 INR
1/21/2026825.45 INR
1/20/2026858.00 INR
1/19/2026871.15 INR
1/16/2026900.10 INR
1/14/2026940.00 INR
1/13/2026926.95 INR
1/12/2026930.70 INR
1/9/2026941.85 INR
1/8/2026962.55 INR
1/7/2026974.50 INR
1/6/2026985.10 INR
1/5/2026950.65 INR
1/2/2026901.50 INR
1/1/2026913.10 INR
12/31/2025900.35 INR
12/30/2025908.10 INR
12/29/2025894.30 INR
12/26/2025911.05 INR
12/24/2025938.30 INR
12/23/2025969.00 INR
12/22/2025952.00 INR
12/19/2025931.00 INR
12/18/2025888.85 INR
12/17/2025877.85 INR
12/16/2025876.00 INR
12/15/2025868.80 INR
12/12/2025885.00 INR
12/11/2025888.15 INR
12/10/2025889.70 INR
12/9/2025885.20 INR
12/8/2025854.30 INR
12/5/2025880.65 INR
12/4/2025887.20 INR
12/3/2025890.00 INR
12/2/2025899.50 INR
12/1/2025911.90 INR
11/28/2025880.80 INR
11/27/2025893.00 INR
11/26/2025903.10 INR
11/25/2025885.70 INR
11/24/2025890.00 INR
11/21/2025895.00 INR
11/20/2025923.40 INR
11/19/2025963.30 INR
11/18/2025965.95 INR
11/17/2025948.75 INR
11/14/2025943.55 INR
11/13/2025973.95 INR
11/12/2025924.10 INR
11/11/2025927.15 INR
11/10/2025928.50 INR
11/7/2025948.25 INR
11/6/2025956.55 INR
11/4/2025962.80 INR
11/3/2025984.80 INR
10/31/2025931.00 INR
10/30/2025848.00 INR
10/29/2025850.55 INR
10/28/2025815.00 INR
10/27/2025815.70 INR
10/24/2025815.00 INR
10/23/2025816.00 INR
10/21/2025810.50 INR
10/20/2025814.25 INR
10/17/2025799.00 INR
10/16/2025808.00 INR
10/15/2025808.40 INR
10/14/2025796.10 INR
10/13/2025831.15 INR
10/10/2025850.85 INR
10/9/2025851.40 INR
10/8/2025796.95 INR
10/7/2025830.15 INR
10/6/2025832.00 INR
10/3/2025827.00 INR
10/1/2025817.00 INR
9/30/2025818.95 INR
9/29/2025815.35 INR
9/26/2025815.50 INR
9/25/2025839.40 INR
9/24/2025844.00 INR
9/23/2025855.00 INR
9/22/2025856.25 INR
9/19/2025875.00 INR
9/18/2025876.60 INR
9/17/2025885.00 INR
9/16/2025877.85 INR
9/15/2025886.10 INR
9/12/2025909.00 INR
9/11/2025914.00 INR
9/10/2025872.45 INR
9/9/2025875.05 INR
9/8/2025879.00 INR
9/5/2025891.80 INR
9/4/2025883.25 INR
9/3/2025896.45 INR
9/2/2025895.95 INR
9/1/2025894.55 INR
8/29/2025863.00 INR
8/28/2025840.00 INR
8/26/2025854.00 INR
8/25/2025902.80 INR
8/22/2025864.80 INR
8/21/2025875.35 INR
8/20/2025880.00 INR
8/19/2025869.45 INR
8/18/2025901.55 INR
8/14/2025895.15 INR
8/13/2025862.00 INR
8/12/2025816.00 INR
8/11/2025797.75 INR
8/8/2025803.50 INR
8/7/2025798.30 INR
8/6/2025805.60 INR
8/5/2025821.80 INR
8/4/2025836.65 INR
8/1/2025836.55 INR
7/31/2025874.10 INR
7/30/2025945.35 INR
7/29/2025954.55 INR
7/28/2025922.35 INR
7/25/2025905.00 INR
7/24/2025918.00 INR
7/23/2025918.90 INR
7/22/2025877.80 INR
7/21/2025891.90 INR
7/18/2025883.00 INR
7/17/2025895.85 INR
7/16/2025917.70 INR
Access this data via the Eulerpool API
Get Free API Key

Strides Pharma Science Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
33.16 B INR
4.33 B INR
2.68 B INR
Jan 1, 2022
30.70 B INR
-2.35 B INR
-4.60 B INR
Jan 1, 2023
36.88 B INR
1.45 B INR
-2.03 B INR
Jan 1, 2024
38.90 B INR
3.71 B INR
-706.12 M INR
Jan 1, 2025
45.65 B INR
6.13 B INR
35.93 B INR
Jan 1, 2026 (e)
49.59 B INR
9.46 B INR
5.20 B INR
Jan 1, 2027 (e)
57.90 B INR
10.91 B INR
6.52 B INR
Jan 1, 2028 (e)
67.85 B INR
0.00 INR
9.06 B INR

Strides Pharma Science Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 5:51 AM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB INR
NET INCOMEB INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
20122014201520162017201820192020202120222023202420252026e2027e2028e
9.6213.4111.9628.6227.5528.4521.7827.5233.1630.7036.8838.9045.6549.5957.9067.85
-62.2839.43-10.83139.35-3.733.26-23.4326.3320.49-7.4120.135.4717.368.6316.7417.19
44.0644.0250.1742.5849.1247.4644.7453.4054.2044.5350.3449.6551.9851.9851.9851.98
4.245.906.0012.1913.5413.509.7514.7017.9713.6718.5719.3123.7325.7830.1035.27
8.4617.678.451.094.006.653.250.362.68-4.60-2.03-0.7135.935.206.529.06
276.93108.78-52.17-87.16268.3966.25-51.15-88.79637.36-271.46-55.98-65.15-5,189.80-85.5325.5138.90
2.00110.00–4.004.502.0015.002.004.002.501.502.504.004.004.595.28
33.335,400.00––12.50-55.56650.00-86.67100.00-37.50-40.0066.6760.00–14.7515.03
59.0059.0060.0083.0090.0090.0090.0090.0090.0090.0090.0891.0092.0292.0292.0292.02
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Strides Pharma Science generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Strides Pharma Science retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Strides Pharma Science's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Strides Pharma Science has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Strides Pharma Science's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Strides Pharma Science stock margins

The Strides Pharma Science margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Strides Pharma Science. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Strides Pharma Science.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
54.20 %
13.05 %
8.09 %
Jan 1, 2022
44.53 %
-7.64 %
-14.99 %
Jan 1, 2023
50.34 %
3.92 %
-5.49 %
Jan 1, 2024
49.65 %
9.54 %
-1.82 %
Jan 1, 2025
51.98 %
13.43 %
78.71 %
Jan 1, 2026 (e)
51.98 %
19.08 %
10.48 %
Jan 1, 2027 (e)
51.98 %
18.85 %
11.27 %
Jan 1, 2028 (e)
51.98 %
0.00 %
13.36 %

Strides Pharma Science Stock Revenue, EBIT, Earnings per Share

The Strides Pharma Science earnings per share therefore indicates how much revenue Strides Pharma Science has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
368.43 INR
48.09 INR
29.82 INR
Jan 1, 2022
341.14 INR
-26.08 INR
-51.13 INR
Jan 1, 2023
409.45 INR
16.06 INR
-22.49 INR
Jan 1, 2024
427.48 INR
40.79 INR
-7.76 INR
Jan 1, 2025
496.12 INR
66.65 INR
390.50 INR
Jan 1, 2026 (e)
538.07 INR
102.81 INR
56.41 INR
Jan 1, 2027 (e)
628.17 INR
118.60 INR
70.79 INR
Jan 1, 2028 (e)
736.16 INR
0.00 INR
98.33 INR

Strides Pharma Science business model & stock analysis

Strides Pharma Science Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Strides Pharma Science historical P/E ratio, EBIT multiple, and P/S ratio

Strides Pharma Science annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Strides Pharma Science shares outstanding

The number of shares of Strides Pharma Science was 92.02 M in 2025. This indicates how many shares Strides Pharma Science is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
90.00 M Stocks
Jan 1, 2022
90.00 M Stocks
Jan 1, 2023
90.08 M Stocks
Jan 1, 2024
91.00 M Stocks
Jan 1, 2025
92.02 M Stocks
Jan 1, 2026 (e)
92.02 M Stocks
Jan 1, 2027 (e)
92.02 M Stocks
Jan 1, 2028 (e)
92.02 M Stocks

Strides Pharma Science stock splits

In Strides Pharma Science's history, there have been no stock splits.

Strides Pharma Science Dividend History

20 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20254.00INR↑ 60.0%1×
Jul 22, 20254.00INR↑ 60.0%1/1
20242.50INR↑ 66.7%1×
20231.50INR↓ 40.0%1×
20222.50INR 0.0%—
20212.50INR↑ 25.0%1×
20202.00INR↓ 86.7%1×
201915.00INR↑ 650.0%2×
20182.00INR↓ 55.6%1×
20174.50INR↑ 12.5%1×
20164.00INR↑ 33.3%1×

Strides Pharma Science dividend history and estimates

In 2025, Strides Pharma Science paid a dividend amounting to 4.00 INR. Dividend means that Strides Pharma Science distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021 (e)
2.50 INR
1.50 INR
0.00 INR
Jan 1, 2022
2.50 INR
0.00 INR
0.00 INR
Jan 1, 2023 (e)
0.00 INR
1.50 INR
0.00 INR
Jan 1, 2024
2.50 INR
0.00 INR
0.00 INR
Jan 1, 2025
4.00 INR
0.00 INR
0.00 INR
Jan 1, 2026
4.00 INR
0.00 INR
0.00 INR
Jan 1, 2027 (e)
0.00 INR
4.59 INR
0.00 INR
Jan 1, 2028 (e)
0.00 INR
5.28 INR
0.00 INR

Strides Pharma Science dividend payout ratio

In 2025, Strides Pharma Science had a payout ratio of 1.02%. The payout ratio indicates the percentage of the company's profits that Strides Pharma Science distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
8.38 %
Jan 1, 2022
19.64 %
Jan 1, 2023
-6.67 %
Jan 1, 2024
-32.26 %
Jan 1, 2025
1.02 %
Jan 1, 2026 (e)
7.09 %
Jan 1, 2027 (e)
6.49 %
Jan 1, 2028 (e)
5.37 %

Current Strides Pharma Science forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.76 %
Buy85.71 % (6)
Hold14.29 % (1)
Sell0.00 % (0)
12M Price Target
1,252.56
Last Price
1,059.60
Currency
INR
12M Return Potential
18.21 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Strides Pharma Science stock

66/100
67
Environment
70
Social
61
Governance
E

Environment

20
Scope 1 - Direct Emissions5,331.8
Scope 2 - Indirect emissions from purchased energy19,893.05
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions25,224.85
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees19.56
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Strides Pharma Science shareholder structure

% Name
17.13091%
Pronomz Ventures, L.L.P.
Pronomz Ventures, L.L.P.
5.40082%
Quant Money Managers Ltd
Quant Money Managers Ltd
3.49902%
Karuna Business Solutions L.L.P.
Karuna Business Solutions L.L.P.
2.23575%
Pillai (Arun Kumar)
Pillai (Arun Kumar)
2.16702%
Route One Investment Company, L.P.
Route One Investment Company, L.P.
2.16328%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
...

Strides Pharma Science Executives and Management Board

AP

Mr. Arun Pillai

(63)

Executive Chairman of the Board · since 2024

Compensation120.00 M INR
BK

Mr. Badree Komandur

(52)

Chief Executive Officer, Managing Director, Executive Director · since 2010

Compensation44.00 M INR
HK

Mr. Homi Khusrokhan

(80)

Non-Executive Independent Director

Compensation4.00 M INR
KS

Dr. Kausalya Santhanam

(57)

Non-Executive Independent Director

Compensation4.00 M INR
MR

Ms. Manjula Ramamurthy

Compliance Officer, Company Secretary

Compensation3.99 M INR

Frequently asked questions about Strides Pharma Science

Analysts currently set an average price target of 1,252.56 INR for the Strides Pharma Science stock (median: 1,252.56 INR), implying +18.2 % versus the latest price. The consensus is based on 7 analyst ratings.

Strides Pharma Science Analyst Price Targets 2026

All fundamentals and in-depth analysis of Strides Pharma Science

Our stock analysis for Strides Pharma Science stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Strides Pharma Science. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Strides Pharma Science Stock
Strides Pharma Science Revenue→
Strides Pharma Science Stock
Strides Pharma Science Net Income→
Strides Pharma Science Stock
Strides Pharma Science P/E→
Strides Pharma Science Stock
Strides Pharma Science P/S→
Strides Pharma Science Stock
Strides Pharma Science EBIT→
Strides Pharma Science Stock
Strides Pharma Science Dividend→
Strides Pharma Science Stock
Strides Pharma Science Directors Dealings→
Strides Pharma Science Stock
Strides Pharma Science Stocks→
Strides Pharma Science Stock
Strides Pharma Science Market capitalization→
Strides Pharma Science Stock
Strides Pharma Science Debt→
Strides Pharma Science Stock
Strides Pharma Science Liabilities→
Strides Pharma Science Stock
Strides Pharma Science Equity→
Strides Pharma Science Stock
Strides Pharma Science AAQS→
Strides Pharma Science Stock
Strides Pharma Science Employees→
Strides Pharma Science Stock
Strides Pharma Science ROE→
Strides Pharma Science Stock
Strides Pharma Science ROA→
Strides Pharma Science Stock
Strides Pharma Science ROCE→
Strides Pharma Science Stock
Strides Pharma Science News→
Strides Pharma Science Stock
Strides Pharma Science Analyst Price Targets→

Health Stocks

StromacelStreamexStructure Therapeutics Inc. American Depositary SharesStraumann HoldingStrykerStrategic Partners A/SSubgen AIStratec SeSugarBud Craft GrowersStrata Skin SciencesSugenTechStoke TherapeuticsAll Stocks A–Z →